Ryo Hisada

814 total citations
42 papers, 549 citations indexed

About

Ryo Hisada is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ryo Hisada has authored 42 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Rheumatology, 14 papers in Immunology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ryo Hisada's work include Systemic Lupus Erythematosus Research (20 papers), Pulmonary Hypertension Research and Treatments (8 papers) and Systemic Sclerosis and Related Diseases (7 papers). Ryo Hisada is often cited by papers focused on Systemic Lupus Erythematosus Research (20 papers), Pulmonary Hypertension Research and Treatments (8 papers) and Systemic Sclerosis and Related Diseases (7 papers). Ryo Hisada collaborates with scholars based in Japan, United States and France. Ryo Hisada's co-authors include Tatsuya Atsumi, Masaru Kato, Yuichiro Fujieda, Shinsuke Yasuda, Toshiyuki Bohgaki, Kenji Oku, Olga Amengual, Michihito Kono, Masatoshi Kanda and George C. Tsokos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ryo Hisada

38 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryo Hisada Japan 14 253 218 120 107 56 42 549
Monica Pendolino Italy 14 361 1.4× 205 0.9× 121 1.0× 156 1.5× 43 0.8× 28 697
Yonsu Son Japan 16 412 1.6× 264 1.2× 162 1.4× 80 0.7× 61 1.1× 49 712
Giuseppe Patuzzo Italy 14 178 0.7× 224 1.0× 93 0.8× 134 1.3× 42 0.8× 23 539
Ziyan Wu China 14 278 1.1× 170 0.8× 97 0.8× 128 1.2× 65 1.2× 68 638
Alessandra Cannizzaro Italy 11 365 1.4× 396 1.8× 161 1.3× 127 1.2× 83 1.5× 17 729
Masahiro Ayano Japan 14 188 0.7× 238 1.1× 50 0.4× 96 0.9× 42 0.8× 40 532
Nozomi Iwanaga Japan 12 238 0.9× 181 0.8× 67 0.6× 158 1.5× 64 1.1× 47 611
Beáta Dérfalvi Canada 14 144 0.6× 271 1.2× 140 1.2× 193 1.8× 52 0.9× 37 644
Patricia Moya Spain 14 253 1.0× 101 0.5× 108 0.9× 128 1.2× 31 0.6× 65 565

Countries citing papers authored by Ryo Hisada

Since Specialization
Citations

This map shows the geographic impact of Ryo Hisada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Hisada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Hisada more than expected).

Fields of papers citing papers by Ryo Hisada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Hisada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Hisada. The network helps show where Ryo Hisada may publish in the future.

Co-authorship network of co-authors of Ryo Hisada

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Hisada. A scholar is included among the top collaborators of Ryo Hisada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Hisada. Ryo Hisada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kono, Michihito, Ryo Hisada, Yuichiro Fujieda, et al.. (2025). Predictive Factors for Renal Outcome During Remission Induction Treatment Period in Lupus Nephritis. International Journal of Rheumatic Diseases. 28(11). e70470–e70470. 1 indexed citations
2.
Shima, Hideki, Ichizo Tsujino, Junichi Nakamura, et al.. (2025). Right Ventricular Dysfunction in Lung Disease/Hypoxia‐Associated Pulmonary Hypertension. Journal of the American Heart Association. 14(16). e042186–e042186.
3.
Hanaoka, Hironari, Akiyoshi Hashimoto, Yusho Ishii, et al.. (2025). A cohort study in HigAshi-nippon of Pulmonary hyPertensIoN in systEmic SclerosiS (HAPPINESS study): protocol and baseline data for an observational study. BMC Rheumatology. 9(1). 25–25.
4.
Kudo, Yuki, Michihito Kono, Masatoshi Kanda, et al.. (2024). Itaconate reduces proliferation and migration of fibroblast-like synoviocytes and ameliorates arthritis models. Clinical Immunology. 264. 110255–110255. 13 indexed citations
5.
Kono, Michihito, et al.. (2024). Relation between hydroxychloroquine dose and continuation rate in patients with systemic lupus erythematosus. Modern Rheumatology. 35(1). 110–117. 2 indexed citations
6.
Saito, Yoshitaka, Yoh Takekuma, Hajime Asahina, Ryo Hisada, & Mitsuru Sugawara. (2024). Significantly Delayed Development of Polyarthritis with Active Tenosynovitis after Possible Temporary Neutropenic Immune-Related Adverse Events Caused by Atezolizumab Treatment: A Novel Case Report. SHILAP Revista de lepidopterología. 2024. 1–5. 1 indexed citations
7.
Umeda, Masataka, Kohei Karino, Abhigyan Satyam, et al.. (2024). Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells, Which Enhances Transforming Growth Factor β1 Activation and Promotes Tissue Fibrosis in Patients With Lupus Nephritis. Arthritis & Rheumatology. 77(2). 180–189. 3 indexed citations
8.
Kono, Michihito, Masatoshi Kanda, Yuki Kudo, et al.. (2023). Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming. Nature Communications. 14(1). 984–984. 84 indexed citations
9.
Kato, Masaru, Ryo Hisada, Mitsutaka Yasuda, et al.. (2023). The chest CT signs for pulmonary veno-occlusive disease correlate with pulmonary haemodynamics in systemic sclerosis. Lara D. Veeken. 63(7). 1868–1873. 4 indexed citations
10.
Onozawa, Masahiro, Yuichiro Fujieda, Ryo Kikuchi, et al.. (2023). Subcutaneous Panniculitis-like T-cell Lymphoma Lacking Subcutaneous Tumor Mimicking Adult-onset Still's Disease. Internal Medicine. 62(21). 3231–3235.
11.
Scherlinger, Marc, Wenliang Pan, Ryo Hisada, et al.. (2022). Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity. Science Advances. 8(48). eadc9657–eadc9657. 34 indexed citations
12.
Kato, Masaru, Hideyuki Ujiie, Ryo Hisada, et al.. (2022). Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study. Lara D. Veeken. 62(7). 2550–2555. 12 indexed citations
13.
Hisada, Ryo, Nobuya Yoshida, Masataka Umeda, et al.. (2022). Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin‐2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 74(7). 1204–1210. 12 indexed citations
14.
Hisada, Ryo, Nobuya Yoshida, Masataka Umeda, et al.. (2022). The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription. Cellular and Molecular Immunology. 19(6). 738–750. 22 indexed citations
15.
Satyam, Abhigyan, Ryo Hisada, Rhea Bhargava, Maria Tsokos, & George C. Tsokos. (2022). Intertwined pathways of complement activation command the pathogenesis of lupus nephritis. Translational research. 245. 18–29. 16 indexed citations
16.
Umeda, Masataka, Nobuya Yoshida, Ryo Hisada, et al.. (2021). ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-β1. Proceedings of the National Academy of Sciences. 118(18). 15 indexed citations
17.
Fujieda, Yuichiro, Takuya Asaka, Masahiro Ota, et al.. (2020). Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease. Journal of Bone and Mineral Metabolism. 38(4). 581–588. 11 indexed citations
18.
Hisada, Ryo, Masaru Kato, Masatoshi Kanda, et al.. (2019). Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation. Journal of Thrombosis and Haemostasis. 17(7). 1134–1143. 27 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026